WuXi AppTec Still Weighing Options for Advanced Therapies Business; Hong Kong Shares Fall 13%

MT Newswires Live10-08

WuXi AppTec (HKG:2359, SHA:6032599) clarified media reports regarding plans to offload its ATU or advanced therapies business, saying it is still weighing its options for the continuation of the business unit, according to a Tuesday filing with the Hong Kong Stock Exchange.

The biotechnology company has not decided on the matter, and is assessing its options according to its priorities of employees and patients, the filing said.

"There is uncertainty as to whether the Company will eventually decide to dispose WuXi ATU," it said in the filing.

Shares plunged 13% in Hong Kong and gained 10% in Shanghai during Tuesday's afternoon trading.

Price (HKD): $59.80, Change: $-9.2, Percent Change: -13.33%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment